fine-tuning biomarker testing to identify and target ret fusions in nsclc
Published 1 year ago • 166 plays • Length 1:14:14Download video MP4
Download video MP3
Similar videos
-
1:39:03
everything you need to know about biomarker testing and treatment of genomically altered nsclc
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies
-
1:07:31
precision decisions in genomic testing and targeted treatment of nsclc
-
1:37:00
find the targets, treat with precision: modern principles and new advances in biomarker-driven nsclc
-
1:26:59
progress in immunotherapy biomarker testing and pathologic response assessment in solid tumors
-
3:18
arrow update confirms pralsetinib benefit for ret fusion-positive advanced nsclc | stephen liu
-
6:32
what is the preferred molecular testing method to detect ret in nsclc?
-
1:13:59
perfecting precision in nsclc practice: are you optimally integrating biomarker-driven therapy?
-
1:24:29
optimizing advanced nsclc biomarker testing, treatment and management session 2
-
0:52
genomic testing is necessary in non-small cell lung cancer
-
7:00
landscape of biomarker testing for nsclc
-
1:20:16
optimizing advanced nsclc biomarker testing, treatment and management session 1
-
1:24:39
optimizing advanced nsclc biomarker testing, treatment and management session 3
-
4:58
treatment of nsclc with ret fusions
-
49:54
practical principles of biomarker testing in advanced non-small cell lung cancer
-
1:01:46
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
48:41
optimizing nsclc treatment with biomarker testing insights
-
5:50
how is biomarker testing carried out?
-
4:37
emerging biomarkers in lung cancer